Bavarian Nordic AS
BV3
Company Profile
Business description
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif.
Contact
Philip Heymans Alle 3
Hellerup2900
DNKT: +45 33268383
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
1,653
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,013.70 | 8.20 | -0.10% |
| CAC 40 | 7,285.86 | 44.11 | -0.60% |
| DAX 40 | 21,205.86 | 105.16 | -0.49% |
| Dow JONES (US) | 38,170.41 | 971.82 | -2.48% |
| FTSE 100 | 8,275.66 | 0.06 | 0.00% |
| HKSE | 21,558.95 | 163.81 | 0.77% |
| NASDAQ | 15,870.90 | 415.55 | -2.55% |
| Nikkei 225 | 34,224.33 | 55.59 | -0.16% |
| NZX 50 Index | 11,836.69 | 282.30 | -2.33% |
| S&P 500 | 5,158.20 | 124.50 | -2.36% |
| S&P/ASX 200 | 7,816.70 | 2.40 | -0.03% |
| SSE Composite Index | 3,306.78 | 15.35 | 0.47% |